Commercial transplants in local Pakistanis from vended kidneys: a socio-economic and outcome study

被引:20
作者
Rizvi, Syed Adibul Hasan [1 ]
Naqvi, Syed Ali Anwar [1 ]
Zafar, Mirza Naqi [1 ]
Mazhar, Farida [1 ]
Muzaffar, Rana [1 ]
Naqvi, Rubina [1 ]
Akhtar, Fazal [1 ]
Ahmed, Ejaz [1 ]
机构
[1] Civil Hosp, Sindh Inst Urol & Transplantat, Karachi 74200, Pakistan
关键词
outcome; recipients; vended kidneys; transplants; RENAL-TRANSPLANTATION; RECIPIENTS; MORTALITY; VENDORS;
D O I
10.1111/j.1432-2277.2009.00836.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Donor shortage and absence of transplant law lead to unrelated commercial transplants in Pakistan. We report the socio-economic and outcome parameters of 126 local recipients of unrelated kidney vendor transplants presenting to our institute between 1997 and 2007. Their outcome was compared with 180 recipients of living-related donor transplants matched for age, gender and transplant duration as controls. Age of commercial recipients was 35.63 +/- 11.57 years with an M:F ratio of 2.4:1. Majority (92%) were transplanted in northern Pakistan paying US$7271 +/- 2198. All were educated with 50% being graduates or above and rich earning a monthly salary of US$517 +/- 518 with 44% earning > US$500. Comparison of commercial recipients with controls showed high comorbidities 35 (28%) vs. 14 (8%) (P = 0.0001) with diabetes, hepatitis-C and cardiovascular diseases. Donor age was 29.97 +/- 6.16 vs. 32.63 +/- 9.3 years (P = 0.035). Biologic agents induction in 101 (80%) vs. 14 (8%) (P = 0.0001), acute rejections in 42 (33%) vs. 31 (17%) (P = 0.005), 1-year creatinine 1.84 +/- 1.28 vs. 1.27 +/- 0.4 mg/dl (P = 0.0001), surgical complications 28 (22%) vs. 14 (8%) (P = 0.001), tuberculosis 14 (11%) vs. 6 (6%) (P = 0.007), acute hepatitis 20 (16%) vs. 3 (2%) (P = 0.0001), cytomegalovirus 33 (26%) vs. 21 (11%) (P = 0.001) and recurrent urinary tract infection 35 (28%) vs. 30 (16%) (P = 0.034). Overall 1- and 5-year graft survival was 86% and 45% vs. 94% and 80%, respectively (P = 0.00001). Total deaths were 34 (27%) vs. 12 (6.0%) (P = 0.001). In conclusion, recipients of the vended kidneys are poor candidates, educated, rich and often self-selecting. Their outcome is poor, which will leave them poorer still and back to dialysis if not death.
引用
收藏
页码:615 / 621
页数:7
相关论文
共 23 条
[11]   Health status and renal function evaluation of kidney vendors: A report from Pakistan [J].
Naqvi, S. A. A. ;
Rizvi, S. A. H. ;
Zafar, M. N. ;
Ahmed, E. ;
Ali, B. ;
Mehmood, K. ;
Awan, M. J. ;
Mubarak, B. ;
Mazhar, F. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (07) :1444-1450
[12]   A socioeconomic survey of kidney vendors in Pakistan [J].
Naqvi, Syed Ali Anwar ;
Ali, Bux ;
Mazhar, Farida ;
Zafar, Mirza Naqi ;
Rizvi, Syed Adibul Hasan .
TRANSPLANT INTERNATIONAL, 2007, 20 (11) :934-939
[13]   Outcomes of commercial renal transplantation: A Canadian experience [J].
Prasad, G. V. Ramesh ;
Shukla, Ashutosh ;
Huang, Michael ;
D'A Honey, R. John ;
Zaltzman, Jeffrey S. .
TRANSPLANTATION, 2006, 82 (09) :1130-1135
[14]   Factors influencing graft survival in living-related donor kidney transplantation at a single center [J].
Rizvi, A ;
Naqvi, A ;
Hussain, Z ;
Hafiz, S ;
Hashmi, A ;
Zafar, N ;
Akhtar, F ;
Ahmed, E ;
Hussain, M ;
Askari, A .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (03) :712-716
[15]  
Rizvi S A H, 2002, Clin Transpl, P191
[16]   Living kidney donor follow-up in a dedicated clinic [J].
Rizvi, SAH ;
Naqvi, SAA ;
Jawad, F ;
Ahmed, E ;
Asghar, A ;
Zafar, MN ;
Akhtar, F .
TRANSPLANTATION, 2005, 79 (09) :1247-1251
[17]   Commercialization of kidney transplants: A systematic review of outcomes in recipients and donors [J].
Sajjad, Imran ;
Baines, Lyndsay S. ;
Patel, Prem ;
Salifu, Moro O. ;
Jindal, Rahul M. .
AMERICAN JOURNAL OF NEPHROLOGY, 2008, 28 (05) :744-754
[18]   Outcome of living unrelated (commercial) renal transplantation [J].
Sever, MS ;
Kazancioglu, R ;
Yildiz, A ;
Türkmen, A ;
Ecder, T ;
Kayacan, SM ;
Çelik, V ;
Sahin, S ;
Aydin, AE ;
Eldegez, U ;
Ark, E .
KIDNEY INTERNATIONAL, 2001, 60 (04) :1477-1483
[19]   Safety and efficacy of basiliximab for the prevention of acute rejection in kidney transplant recipients [J].
Shah, MH ;
Bokhari, MZM ;
Bokhari, MTM ;
Farooq, A ;
Yousaf, SM .
TRANSPLANTATION PROCEEDINGS, 2003, 35 (07) :2737-2738
[20]  
Vazquezs MA, 2005, MED MANAGEMENT KIDNE, P26